X

Health Care

IPO News: Should you invest in Sight Sciences’ initial public offering?

The continuing stock market rally, at a time when the pandemic-hit economy is struggling to regain strength, has set off…

Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript

Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2021 earnings call dated Jun. 29, 2021 Corporate Participants: Tim Brons -- Executive Vice President, Vida…

Aerovate Therapeutics IPO: What awaits the biotech firm after market debut?

The IPO market has continued the bull run so far this year, unfazed by the virus-related uncertainties, with the technology…

Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why

For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was…

Rite Aid Corporation (RAD) Q1 2022 Earnings Call Transcript

Rite Aid Corporation (NYSE: RAD) Q1 2022 earnings call dated Jun. 24, 2021 Corporate Participants: Trent Kruse -- Senior Vice President, Investor…

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in…

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for…

Patterson Companies, Inc. (PDCO) Q4 2021 Earnings Call Transcript

Patterson Companies, Inc. (NASDAQ: PDCO) Q4 2021 earnings call dated Jun. 23, 2021 Corporate Participants: John M. Wright -- Vice President, Investor…

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding…

IPO News: What to look for when Elevation Oncology makes its Wall Street debut

The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that…

Trxade Health Inc. (NASDAQ: MEDS) Q2 2021 Research Summary

Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare…

BeyondSpring, Inc.(BYSI) Q1 2021 Earnings Call Transcript

BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson -- Media & Investor Relations…

Is Merck (MRK) stock still a buy after losing the vaccine race?

After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the…

LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?

For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges…

HealthEquity Inc (HQY) Q1 2022 Earnings Call Transcript

HealthEquity Inc (NASDAQ:HQY) Q1 2022 earnings call dated Jun. 07, 2021. Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President and Chief…

Cupid Limited (CUPID) Q4 2021 Earnings Call Transcript

Cupid Limited (NSE:CUPID) Q4 2021 earnings call dated Jun. 04, 2021 Corporate Participants: Binay Sarda -- Christensen Investor Relations Om Prakash Garg -- Chairman…

Medtronic PLC (MDT) Q4 2021 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q4 2021 earnings call dated May 27, 2021 Corporate Participants: Ryan Weispfenning -- Vice President, Investor Relations Karen…

Agilent Technologies Inc (A) Q2 2021 Earnings Call Transcript

Agilent Technologies Inc (NYSE:A) Q2 2021 earnings call dated May. 25, 2021. Corporate Participants: Ruben DiRado -- Director, Investor Relations Mike McMullen -- President…

Moderna, Inc. (MRNA) Q1 2021 Earnings Call

Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Lavina Talukdar — Senior Vice President and Head of…

Bio-Path Holdings, Inc. (BPTH) Q1 2021 Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q1 2021 earnings call dated May. 14, 2021 Corporate Participants: Will O'Connor -- Investor Relations, Stern Investor…

ImmunoGen’s post-earnings dip could be a good buying opportunity

Earlier this week, biotech company ImmunoGen (NASDAQ: IMGN) reported mixed financial results for the first quarter of 2021, pushing the…